Literature DB >> 8453961

Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.

P A Soons1, T M Mulders, E Uchida, H C Schoemaker, A F Cohen, D D Breimer.   

Abstract

The pharmacokinetics of racemic (rac) felodipine, rac-nitrendipine and nifedipine (all given as an oral dose of 20 mg in solution) have been investigated in a randomised cross-over study in 12 healthy male subjects using stereoselective assays. Both felodipine and nitrendipine exhibited stereoselective pharmacokinetics. On average, the AUCs of the active (S)-enantiomers of felodipine and nitrendipine were 139% and 104% higher than those of their optical antipodes, but the elimination half-lives of the enantiomers of each racemate were not different. The AUCs of nifedipine, rac-felodipine, rac-nitrendipine and of their enantiomers were highly correlated (all r > 0.83), suggesting closely related rate limiting steps in the in vivo first-pass metabolism of these high-clearance drugs. Stereoselectivity was only a minor contributor to inter-individual variability in the oral pharmacokinetics of these compounds in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453961     DOI: 10.1007/bf00315475

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  40 in total

Review 1.  Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatographic methodology.

Authors:  P A Soons; J H Schellens; M C Roosemalen; D D Breimer
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

2.  Serum binding of nifedipine and verapamil in patients with ischaemic heart disease on monotherapy.

Authors:  D O Rumiantsev; V K Piotrovskii; V I Metelitsa; I D Slastnikova; E V Kokurina
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  Elimination and haemodynamic effects of nitrendipine in patients with chronic renal failure.

Authors:  T Ankermann; U Osterkamp; S R Santos; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Inter- and intra-subject variability of nitrendipine and the effects of food.

Authors:  J Lobo; D B Jack; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The trans-hepatic extraction of nifedipine.

Authors:  V F Challenor; D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

6.  Gas chromatographic analysis of nitrendipine and its pyridine metabolite in human plasma.

Authors:  P A Soons; D D Breimer
Journal:  J Chromatogr       Date:  1988-07-15

7.  Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma.

Authors:  P A Soons; M C Roosemalen; D D Breimer
Journal:  J Chromatogr       Date:  1990-06-29

8.  Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines.

Authors:  F P Guengerich; R H Böcker
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  The metabolism of nicardipine hydrochloride in healthy male volunteers.

Authors:  W R Rush; O Alexander; D J Hall; L Cairncross; R J Dow; D J Graham
Journal:  Xenobiotica       Date:  1986-04       Impact factor: 1.908

10.  Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.

Authors:  P Bellemann; A Schade; R Towart
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more
  4 in total

1.  CYP3A4 drug interactions: correlation of 10 in vitro probe substrates.

Authors:  K E Kenworthy; J C Bloomer; S E Clarke; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Relationship of changes in felodipine pharmacokinetics to haemodynamics during chronic oral treatment of congestive heart failure patients.

Authors:  A H Scaf; P H Dunselman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Determination of (+)- and (-)-nicardipine concentrations in human serum and their correlation with the antihypertensive effect after oral administration of racemic nicardipine.

Authors:  T Iwaoka; N Inotsume; J Inoue; S Naomi; Y Okamoto; S Higuchi; M Nakano; T Umeda
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.

Authors:  Laura Maria Fuhr; Fatima Zahra Marok; Maximilian Mees; Felix Mahfoud; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.